Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GYRE · against 449 other Healthcare companies of similar size
Ranked #313 of 450 · scores higher than 31% of peers · safety percentile 35
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)38 peers with a safety percentile of 30–39, including GYRE · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GYRE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 417 reported | 0.02× | 0.17× | 81% | 33% | |
| BetaLower is better · 431 reported | 4.74 | 0.43 | 0% | 33% | |
| Current ratioHigher is better · 443 reported | 4.26× | 2.89× | 64% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 309 | 2.6B CNY (≈$359M) | 37 | 52 | |
| 310 | 11.6B THB (≈$324M) | 37 | 38 | |
| 311 | 86.8B JPY (≈$590M) | 36 | 60 | |
| 312 | 3.3B CNY (≈$463M) | 35 | 26 | |
| 313 | 471M USD | 35 | 21 | |
| 314 | 2.8B CNY (≈$394M) | 35 | 39 | |
| 315 | 23.7B INR (≈$284M) | 34 | 58 | |
| 316 | 395M USD | 34 | 30 | |
| 317 | 5.8B HKD (≈$739M) | 34 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score